Search research articles
Contact Us
Filters
Showing results (161-170 of 242) with videos related to
Page
of 25
Sort By:
British Journal of Cancer
|
February 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
Jerold Loh, Jiaxuan Wu, Jenny Chieng, et al.
Molecular Cancer Therapeutics
|
October 22, 2016
Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, et al.
Thoracic Cancer
|
September 30, 2022
Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer
Yiqing Huang, Joseph J Zhao, Yu Yang Soon, et al.
Iscience
|
July 23, 2025
A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline
Zheng Yen Phua, Ming Li, Azhar Ali, et al.
Molecular Cancer Therapeutics
|
May 6, 2015
MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
Li Ren Kong, Kian Ngiap Chua, Wen Jing Sim, et al.
Oncogene
|
December 20, 2017
Dual role of autophagy in hallmarks of cancer
Shikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, et al.
Targeted Oncology
|
February 23, 2022
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Matilda Xinwei Lee, Andrea L A Wong, Samuel Ow, et al.
Theranostics
|
October 21, 2024
Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance
Jayshree Hirpara, Win Lwin Thuya, Sok-Hwee Cheow, et al.
Ebiomedicine
|
March 15, 2024
Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma
Harue Mizokami, Atsushi Okabe, Ruchi Choudhary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer
Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 242) with videos related to
Sort By:
Page
of 25
British Journal of Cancer
|
February 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
Jerold Loh, Jiaxuan Wu, Jenny Chieng, et al.
Molecular Cancer Therapeutics
|
October 22, 2016
Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, et al.
Thoracic Cancer
|
September 30, 2022
Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer
Yiqing Huang, Joseph J Zhao, Yu Yang Soon, et al.
Iscience
|
July 23, 2025
A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline
Zheng Yen Phua, Ming Li, Azhar Ali, et al.
Molecular Cancer Therapeutics
|
May 6, 2015
MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
Li Ren Kong, Kian Ngiap Chua, Wen Jing Sim, et al.
Oncogene
|
December 20, 2017
Dual role of autophagy in hallmarks of cancer
Shikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, et al.
Targeted Oncology
|
February 23, 2022
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Matilda Xinwei Lee, Andrea L A Wong, Samuel Ow, et al.
Theranostics
|
October 21, 2024
Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance
Jayshree Hirpara, Win Lwin Thuya, Sok-Hwee Cheow, et al.
Ebiomedicine
|
March 15, 2024
Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma
Harue Mizokami, Atsushi Okabe, Ruchi Choudhary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer
Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, et al.
Page
of 25